Related Experiment Video
Updated: Jun 12, 2026
10:48
SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval
Published on: April 23, 2010
24.7K
A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis
Francesca Nuti1, Feliciana Real Fernandez1, Giuseppina Sabatino1,2
1Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 13, 50019 Sesto Fiorentino, Italy.
Brain Sciences
|July 19, 2020
Summary
Researchers developed new Multiple N-glucosylated Peptide Epitopes (N-Glc MEPs) for detecting anti-N-Glc antibodies in Multiple Sclerosis (MS) patients. This assay offers a potential alternative for monitoring MS disease activity.
Area of Science:
- Immunology
- Neuroscience
- Biochemistry
Background:
- Multiple Sclerosis (MS) diagnosis relies heavily on MRI, with limited simple assays for disease activity monitoring.
- Identifying fluctuating antibody biomarkers in biological fluids is crucial for understanding MS immune responses.
- Previous work identified anti-N-glucosylated (N-Glc) peptide antibodies in MS sera recognizing Haemophilus Influenzae.
Purpose of the Study:
- To develop a multivalent assay for detecting anti-N-Glc antibodies in MS patients.
- To identify optimal N-Glc peptide sequences for antibody recognition.
- To create a diagnostic tool for MS immune response monitoring.
Main Methods:
- Development of a collection of Multiple N-glucosylated Peptide Epitopes (N-Glc MEPs).
- Testing of N-Glc peptide antigens in competitive ELISA to determine minimal epitope requirements.
- Utilizing a 4-branched dendrimeric lysine scaffold to create multivalent probes.
Main Results:
- Confirmed that the minimal epitope requires at least a 5-mer sequence including the N-Glc moiety.
- Selected N-Glc MEP 24, featuring the minimal Asn(Glc) epitope linked to a PEG spacer, as an efficient probe.
- Demonstrated that N-Glc MEP 24 effectively detects specific, high-affinity anti-N-Glc antibodies in MS patients.
Conclusions:
- N-Glc MEPs, particularly N-Glc MEP 24, serve as efficient multivalent probes for anti-N-Glc antibodies.
- This assay shows promise as a simple, alternative method for monitoring MS disease activity.
- The findings contribute to the development of novel biomarkers for immune response in MS.
